Search research articles
Contact Us
Filters
Showing results (51-60 of 73) with videos related to
Page
of 8
Sort By:
Mucosal Immunology
|
March 6, 2024
The bacterial lysate OM-85 engages Toll-like receptors 2 and 4 triggering an immunomodulatory gene signature in human myeloid cells
Hanif J Khameneh, Marco Bolis, Pedro M O Ventura, et al.
EMBO Molecular Medicine
|
April 19, 2015
Cellular and molecular determinants of all-trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RARα expression
Floriana Centritto, Gabriela Paroni, Marco Bolis, et al.
Cell Death & Disease
|
July 22, 2024
Onvansertib treatment overcomes olaparib resistance in high-grade ovarian carcinomas
Michela Chiappa, Alessandra Decio, Luca Guarrera, et al.
Molecular Cell
|
June 9, 2023
Minor intron splicing is critical for survival of lethal prostate cancer
Anke Augspach, Kyle D Drake, Luca Roma, et al.
Nature Communications
|
February 23, 2025
Increased ectodysplasin-A2-receptor EDA2R is a ubiquitous hallmark of aging and mediates parainflammatory responses
Maria Chiara Barbera, Luca Guarrera, Andrea David Re Cecconi, et al.
Oncogene
|
September 2, 2025
Integrated control of cancer stemness by σ<sub>1</sub> receptor in advanced prostate cancer
Gianluca Civenni, Giada Sandrini, Jessica Merulla, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
June 19, 2025
Mesenchymal Stromal Cell Secretome and Its Key Bioactive Metabolites Induce Long-Term Neuroprotection After Traumatic Brain Injury in Mice
Francesca Pischiutta, Francesca Tribuzio, Marta Magatti, et al.
Cell Death & Disease
|
February 17, 2025
Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment
Ersilia Varone, Michele Retini, Alessandro Cherubini, et al.
Cell Reports
|
June 15, 2025
An integrated proteomic portrait of prostate cancer progression
Jichang Zhang, Keith D Rivera, Daniela Bossi, et al.
Cell Reports. Medicine
|
February 25, 2024
SEPN1-related myopathy depends on the oxidoreductase ERO1A and is druggable with the chemical chaperone TUDCA
Serena Germani, Andrew Tri Van Ho, Alessandro Cherubini, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 73) with videos related to
Sort By:
Page
of 8
Mucosal Immunology
|
March 6, 2024
The bacterial lysate OM-85 engages Toll-like receptors 2 and 4 triggering an immunomodulatory gene signature in human myeloid cells
Hanif J Khameneh, Marco Bolis, Pedro M O Ventura, et al.
EMBO Molecular Medicine
|
April 19, 2015
Cellular and molecular determinants of all-trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RARα expression
Floriana Centritto, Gabriela Paroni, Marco Bolis, et al.
Cell Death & Disease
|
July 22, 2024
Onvansertib treatment overcomes olaparib resistance in high-grade ovarian carcinomas
Michela Chiappa, Alessandra Decio, Luca Guarrera, et al.
Molecular Cell
|
June 9, 2023
Minor intron splicing is critical for survival of lethal prostate cancer
Anke Augspach, Kyle D Drake, Luca Roma, et al.
Nature Communications
|
February 23, 2025
Increased ectodysplasin-A2-receptor EDA2R is a ubiquitous hallmark of aging and mediates parainflammatory responses
Maria Chiara Barbera, Luca Guarrera, Andrea David Re Cecconi, et al.
Oncogene
|
September 2, 2025
Integrated control of cancer stemness by σ<sub>1</sub> receptor in advanced prostate cancer
Gianluca Civenni, Giada Sandrini, Jessica Merulla, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
June 19, 2025
Mesenchymal Stromal Cell Secretome and Its Key Bioactive Metabolites Induce Long-Term Neuroprotection After Traumatic Brain Injury in Mice
Francesca Pischiutta, Francesca Tribuzio, Marta Magatti, et al.
Cell Death & Disease
|
February 17, 2025
Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment
Ersilia Varone, Michele Retini, Alessandro Cherubini, et al.
Cell Reports
|
June 15, 2025
An integrated proteomic portrait of prostate cancer progression
Jichang Zhang, Keith D Rivera, Daniela Bossi, et al.
Cell Reports. Medicine
|
February 25, 2024
SEPN1-related myopathy depends on the oxidoreductase ERO1A and is druggable with the chemical chaperone TUDCA
Serena Germani, Andrew Tri Van Ho, Alessandro Cherubini, et al.
Page
of 8